We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
-14.47%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$5.96B
AUM Growth
-$2.66B
Cap. Flow
-$2.46B
Cap. Flow %
-41.33%
Top 10 Hldgs %
19.41%
Holding
1,586
New
385
Increased
156
Reduced
122
Closed
320

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$45.3M
2
DELL icon
Dell
DELL
+$42.5M
3
JD icon
JD.com
JD
+$38.9M
4
TSM icon
TSMC
TSM
+$32.4M
5
ACC
American Campus Communities, Inc.
ACC
+$31.6M

Sector Composition

Rank Sector Weight
1 Technology 20.75%
2 Financials 9.38%
3 Healthcare 5.16%
4 Consumer Discretionary 4.89%
5 Communication Services 4.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRDF icon
1151
Cardiff Oncology
CRDF
$65M
$30K ﹤0.01%
+13,584
New +$22.8K
CRVS icon
1152
Corvus Pharmaceuticals
CRVS
$1.09B
$30K ﹤0.01%
30,000
QMCO icon
1153
Quantum Corp
QMCO
$432M
$30K ﹤0.01%
+1,057
New +$40K
DTIL icon
1154
Precision BioSciences
DTIL
$187M
$29K ﹤0.01%
+601
New +$35.3K
FBIO icon
1155
Fortress Biotech
FBIO
$109M
$29K ﹤0.01%
+2,326
New +$34.5K
VATE icon
1156
INNOVATE Corp
VATE
$116M
$29K ﹤0.01%
+1,689
New +$46.2K
LENZ
1157
LENZ Therapeutics
LENZ
$179M
$29K ﹤0.01%
+1,504
New +$33.5K
QTTB icon
1158
Q32 Bio
QTTB
$452M
$29K ﹤0.01%
+831
New +$28.4K
IMDX
1159
Insight Molecular Diagnostics
IMDX
$152M
$28K ﹤0.01%
+1,573
New +$35.8K
NAGE
1160
Niagen Bioscience
NAGE
$257M
$28K ﹤0.01%
+16,717
New +$32.7K
NMTR
1161
DELISTED
9 Meters Biopharma
NMTR
$28K ﹤0.01%
+5,384
New +$50.7K
ARDX icon
1162
Ardelyx
ARDX
$1.25B
$27K ﹤0.01%
+45,956
New +$33.8K
RJET
1163
Republic Airways Holdings
RJET
$839M
$27K ﹤0.01%
+825
New +$38.8K
VHC icon
1164
VirnetX Holding Corp
VHC
$51M
$26K ﹤0.01%
+1,131
New +$31.5K
SYRS
1165
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$26K ﹤0.01%
+2,738
New +$25.6K
PSTX
1166
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$26K ﹤0.01%
+10,258
New +$28.5K
LTRPA
1167
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$26K ﹤0.01%
+34,652
New +$44.6K
INFI
1168
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$26K ﹤0.01%
+41,631
New +$32K
ATHX
1169
DELISTED
Athersys, Inc. Common Stock
ATHX
$26K ﹤0.01%
+4,051
New +$44.8K
LVO icon
1170
LiveOne
LVO
$64.1M
$25K ﹤0.01%
+2,897
New +$23.8K
SPRU icon
1171
Spruce Power Holding Corp
SPRU
$39.1M
$25K ﹤0.01%
+2,671
New +$30.8K
TAST
1172
DELISTED
Carrols Restaurant Group, Inc.
TAST
$24K ﹤0.01%
+11,924
New +$22.3K
AKBA icon
1173
Akebia Therapeutics
AKBA
$343M
$23K ﹤0.01%
+64,849
New +$27.2K
SIEN
1174
DELISTED
Sientra, Inc.
SIEN
$23K ﹤0.01%
+2,761
New +$37.6K
EVLO
1175
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$23K ﹤0.01%
+542
New +$25.1K

Similar funds

LMR Partners's Q2 2022 Portfolio in Review

As of Q2 2022, LMR Partners held 1,586 positions worth $5.96B, down 31% from $8.61B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

LMR Partners withdrew a net $2.46B in Q2 2022, closing 320 positions and reducing 122 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $117M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, LMR Partners opened a new position in Microsoft worth $42.8M.

  • LMR Partners's largest Q2 2022 buy was Microsoft: 166,753 shares worth $42.8M.
  • LMR Partners added most to TSMC in Q2 2022, an estimated $32.4M increase.
  • LMR Partners's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $553M.
  • LMR Partners fully exited Invesco QQQ Trust in Q2 2022, selling an estimated $117M.
  • LMR Partners's ten largest holdings make up 19% of its $5.96B portfolio in Q2 2022.
  • LMR Partners opened 385 new positions and closed 320 in Q2 2022.
  • LMR Partners's portfolio value fell 31% quarter-over-quarter to $5.96B.

Based on LMR Partners's 13F filing for Q2 2022, filed 15 Aug 2022.